RNA$6.43-14.38%
Atrium Therapeutics, Inc.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap & EV:$138.7M /
Float & O/S:15.88M / 21.57M
Est. Net Cash/Sh:
Inst Own:64.3%
DilutionScan read 28 of Atrium Therapeutics, Inc.'s SEC filings and found 1 warrant series and 1 completed offering on file for RNA. The latest dilution event on file is an offering on Oct 9, 2026. Analysis updated Nov 14, 2026.